Safety and Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic stem cell transplantation (alloHCT)

Due to the morbidity and mortality of meningococcal disease, the Advisory Committee of Immunization Practices recommended in 2007 immunization of all children 11–18 years old with a protein-conjugated meningococcal vaccine. There is limited data on the immunogenicity of this vaccine following alloHC...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Mahler, Michelle B., Taur, Ying, Jean, Raymond, Kernan, Nancy A, Prockop, Susan E, Small, Trudy N.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286795/
https://ncbi.nlm.nih.gov/pubmed/21820392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.027
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg